ArticleBMC cancer2019

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study.

L Perkhofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.